Biologics

Spinal Implants

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

BELGRADE, Mont. , March 21, 2024 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and